Cancer Research Prevention Award  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, W.
Right arrow Articles by Schroit, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, W.
Right arrow Articles by Schroit, A. J.
[Cancer Research 65, 913-918, February 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Vascularization of Melanoma by Mobilization and Remodeling of Preexisting Latent Vessels to Patency

Weixin Lu and Alan Jay Schroit

Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Alan Jay Schroit, Department of Cancer Biology (173), University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-792-8586; Fax: 713-792-8747; E-mail: aschroit{at}mdanderson.org.

Tumors must manipulate the host vasculature to provide a blood supply adequate for their proliferation. Although tumors may arise as avascular masses, there is increasing evidence that some tumors begin to proliferate by first co-opting preexisting host blood vessels. By fluorescent vascular imaging, we provide evidence that the vasculature in orthotopically implanted melanoma arises from a preexisting red cell–deficient vascular network that remodels to patency to accommodate the requirements of the expanding tumor mass. Topical application of vascular endothelial growth factor to vascular beds generated immediate and robust vascular transitions that were morphologically similar to tumor-induced transitions. N{varphi}-nitro-L-arginine, a nitric oxide inhibitor, significantly inhibited the growth of a syngeneic K1735M2 melanoma by reducing blood supply to the tumor by a mechanism independent of endothelial cell proliferation. These findings suggest that tumor-induced remodeling of red cell–deficient vessels to patency contributes to tumor vascularization and growth.

Key Words: tumor microvasculature • blood vessel perfusion • melanoma • angiogenesis




This article has been cited by other articles:


Home page
Cancer Res.Home page
C.-N. Qian, B. Berghuis, G. Tsarfaty, M. Bruch, E. J. Kort, J. Ditlev, I. Tsarfaty, E. Hudson, D. G. Jackson, D. Petillo, et al.
Preparing the "Soil": The Primary Tumor Induces Vasculature Reorganization in the Sentinel Lymph Node before the Arrival of Metastatic Cancer Cells
Cancer Res., November 1, 2006; 66(21): 10365 - 10376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Marcellini, N. De Luca, T. Riccioni, A. Ciucci, A. Orecchia, P. M. Lacal, F. Ruffini, M. Pesce, F. Cianfarani, G. Zambruno, et al.
Increased Melanoma Growth and Metastasis Spreading in Mice Overexpressing Placenta Growth Factor
Am. J. Pathol., August 1, 2006; 169(2): 643 - 654.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. R. Camp, A. Yang, W. Liu, F. Fan, R. Somcio, D. J. Hicklin, and L. M. Ellis
Roles of Nitric Oxide Synthase Inhibition and Vascular Endothelial Growth Factor Receptor-2 Inhibition on Vascular Morphology and Function in an In vivo Model of Pancreatic Cancer
Clin. Cancer Res., April 15, 2006; 12(8): 2628 - 2633.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Chen, B. W. Pogue, J. M. Luna, R. L. Hardman, P. J. Hoopes, and T. Hasan
Tumor Vascular Permeabilization by Vascular-Targeting Photosensitization: Effects, Mechanism, and Therapeutic Implications
Clin. Cancer Res., February 1, 2006; 12(3): 917 - 923.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Weihua, R. Tsan, A. J. Schroit, and I. J. Fidler
Apoptotic Cells Initiate Endothelial Cell Sprouting via Electrostatic Signaling
Cancer Res., December 15, 2005; 65(24): 11529 - 11535.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. R. Kim, A. Yudina, J. Figueiredo, W. Reichardt, D. Hu-Lowe, A. Petrovsky, H. W. Kang, D. Torres, U. Mahmood, R. Weissleder, et al.
Detection of Early Antiangiogenic Effects in Human Colon Adenocarcinoma Xenografts: In vivo Changes of Tumor Blood Volume in Response to Experimental VEGFR Tyrosine Kinase Inhibitor
Cancer Res., October 15, 2005; 65(20): 9253 - 9260.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. A. Wood, K. Bove, S. You, A. Chambers, and W. J.M. Hrushesky
Cancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesis
Mol. Cancer Ther., July 1, 2005; 4(7): 1065 - 1075.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.